NHS Digital Platform: Promised Benefits or Inflated Statistics?
Data discrepancies and lack of hospital engagement cast doubt on the performance of the £330 million health system project.
Official data released by NHS England highlighting the success of the Palantir Federated Data Platform (FDP) has faced significant criticism. While the NHS public register claims that 29 hospitals and medical facilities are actively using the platform and reaping "real benefits," it has emerged that many of these institutions are not using the system at all, or it has not yet been activated for them.
Discrepancies Between Official Data and Reality
The scandal broke after the medical charity Medact submitted Freedom of Information requests and published the responses. It revealed that hospitals such as Nottingham University Hospitals and the University Hospitals of North Midlands explicitly stated they had not implemented the platform and had no future plans to do so. Despite this, they were included in NHS statistics among the 137 facilities said to have benefited from the system.
NHS England explains this discrepancy by noting that their list includes institutions using the platform solely for processing administrative data rather than direct patient care. However, health experts have labelled this approach "highly misleading."
The Purpose of the Palantir Platform
The £330 million project launched in April 2024. Its primary goal is to consolidate fragmented medical records, accelerate the patient discharge process, and optimise surgical scheduling. Palantir representatives claim the software has facilitated 117,000 more operations than would have been possible without the system.
Nevertheless, even the NHS website acknowledges that it is "impossible to establish a causal link" from these statistics. Consequently, the Office for Statistics Regulation has begun reviewing the information provided by the NHS.
What Comes Next?
The issue has taken on a political dimension. Chi Onwurah, chair of the Science and Technology Committee, has urged the government to utilise the 2027 contract break clause and hold an open tender involving British companies. She argues that if medical facilities themselves do not understand the value of the platform, it raises questions about whether the hype surrounding Palantir’s products reflects reality.
For its part, Palantir leadership claims that terminating the contract would mean "putting politics above patients." However, public dissatisfaction is growing: in September, 44,000 people formally registered their protest against the use of the platform. This case highlights the complexities of centralising data management systems in the healthcare sector and the importance of transparency when handling confidential patient information.